Rapamycin rescues BMP mediated midline craniosynostosis phenotype through reduction of mTOR signaling in a mouse model
genesis · 2018-06 · 56 (6-7)
DOI: 10.1002/dvg.23220 ↗Kurz gefasst
Fachartikel in der Zeitschrift genesis, online erschienen am 08.08.2018. Verfasst von Kaitrin Kramer und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biologic & Materials Sciences, School of Dentistry, University Michigan, Ann Arbor, Michigan, 48109. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 72 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDCR NIH HHS, National Institutes of Health, National Natural Science Foundation of China.
Abstract (Originalsprache)
Craniosynostosis is defined as congenital premature fusion of one or more cranial sutures. While the genetic basis for about 30% of cases is known, the causative genes for the diverse presentations of the remainder of cases are unknown. The recently discovered cranial suture stem cell population affords an opportunity to identify early signaling pathways that contribute to craniosynostosis. We previously demonstrated that enhanced BMP signaling in neural crest cells (caA3 mutants) leads to premature cranial suture fusion resulting in midline craniosynostosis. Since enhanced mTOR signaling in neural crest cells leads to craniofacial bone lesions, we investigated the extent to which mTOR signaling is involved in the pathogenesis of BMP‐mediated craniosynostosis by affecting the suture stem cell population. Our results demonstrate a loss of suture stem cells in the caA3 mutant mice by the newborn stage. We have found increased activation of mTOR signaling in caA3 mutant mice during embryonic stages, but not at the newborn stage. Our study demonstrated that inhibition of mTOR signaling via rapamycin in a time specific manner partially rescued the loss of the suture stem cell population. This study provides insight into how enhanced BMP signaling regulates suture stem cells via mTOR activation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biologic & Materials Sciences, School of Dentistry, University Michigan, Ann Arbor, Michigan, 48109.
- Department of Orthodontics, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.
- Los Angeles School of Dentistry, Section of Periodontics, University of California, Los Angeles, California, 90095.
Förderung
- NIDCR NIH HHS
- National Institutes of Health
- National Natural Science Foundation of China
Zitieren
APA
Kramer, K., Yang, J., Swanson, W. B., Hayano, S., Toda, M., Pan, H., Kim, J. K., Krebsbach, P. H., & Mishina, Y. (2018). Rapamycin rescues BMP mediated midline craniosynostosis phenotype through reduction of mTOR signaling in a mouse model. genesis, 56(6-7). https://doi.org/10.1002/dvg.23220
Vancouver
Kramer K, Yang J, Swanson WB, Hayano S, Toda M, Pan H, et al. Rapamycin rescues BMP mediated midline craniosynostosis phenotype through reduction of mTOR signaling in a mouse model. genesis. 2018;56(6-7). doi:10.1002/dvg.23220
BibTeX
@article{Kramer2018,
author = {Kramer, Kaitrin and Yang, Jingwen and Swanson, W Benton and Hayano, Satoru and Toda, Masako and Pan, Haichun and Kim, Jin Koo and Krebsbach, Paul H and Mishina, Yuji},
title = {Rapamycin rescues BMP mediated midline craniosynostosis phenotype through reduction of mTOR signaling in a mouse model},
journal = {genesis},
year = {2018},
volume = {56},
number = {6-7},
doi = {10.1002/dvg.23220}
}
EUVIMED